What happens when promising laboratory research collides with an unregulated online market? The so-called "Wolverine stack," a combination of experimental peptides known as BPC-157 and TB-500, has attracted attention from people looking for faster recovery and potential anti-aging effects. In this episode, we explore what scientists actually know about these compounds, separating intriguing findings from the much more limited evidence available in humans. We examine why substances that appear promising in animal research can remain far from established medical treatments, and how legal uncertainty and the research-chemical market have allowed informal experimentation to flourish online. We also investigate the risks created by limited oversight, including uncertainty around product quality, dosing, and long-term effects. Ultimately, the story rev ...